Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis

Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis

Oxidative stress is known to be associated with the pathophysiology of chronic kidney disease (CKD). Paraoxonase 1 (PON1) is an antioxidant enzyme that has been proposed as a biomarker for CKD. While several studies have reported an association between serum PON1 activity and CKD, consensus based on...

Full description

Bibliographic Details
Main Authors:	Jun Watanabe, Kazuhiko Kotani, Alejandro Gugliucci
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Journal of Clinical Medicine
Subjects:	antioxidants arylesterase cardiovascular disease kidney failure paraoxonase reactive oxygen species
Online Access:	https://www.mdpi.com/2077-0383/12/3/1199

Similar Items

Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis
by: Jun Watanabe, et al.
Published: (2021-11-01)

Paraoxonase 1 Activity and Renal Replacement Therapy for Chronic Renal Failure: A Meta-Analysis
by: Jun Watanabe, et al.
Published: (2023-08-01)

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Kazuhiko Kotani, et al.
Published: (2021-04-01)

Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
by: Nurhan Sarioglu, et al.
Published: (2015-02-01)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
by: Angelo Zinellu, et al.
Published: (2023-07-01)

Evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
by: Ayan Durmu§, et al.
Published: (2019-01-01)

Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure
by: H Toy, et al.
Published: (2009-02-01)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
by: Fazile Hatipoglu Erdem, et al.
Published: (2010-01-01)

Serum arylesterase and paraoxonase activities in patients with ovarian tumors
by: Slawomir Michalak, et al.
Published: (2014-12-01)

Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma
by: Feyza Dursun, et al.
Published: (2015-10-01)

Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy
by: Hande Koksal, et al.
Published: (2010-01-01)

Serum Lipid Profiles, Relationship Between Paraoxonase/Arylesterase Activity and High-density Lipoprotein Levels in Patients with Migraine
by: Yasemin Eren, et al.
Published: (2017-09-01)

Relationship of Serum Paraoxonase Enzyme Activity and Thermal Burn Injury
by: Serap Yildirim, et al.
Published: (2012-12-01)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
by: Ajda Taler-Verčič, et al.
Published: (2020-12-01)

Effects of PON1 QR192 genetic polymorphism and paraoxonase, arylesterase activities on deep vein thrombosis
by: Akbalik Hasim, et al.
Published: (2023-05-01)

Evaluation of Serum malondialdehyde concentrations and enzymatic activity of paraoxonase and arile esterase in women with a recurrent spontaneous abortion
by: Sanjadi M, et al.
Published: (2019-12-01)

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
by: Alexander C. Reisinger, et al.
Published: (2020-10-01)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
by: Arianna Romani, et al.
Published: (2020-05-01)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
by: George Awuku Asare, et al.
Published: (2018-03-01)

Arylesterase activity of Paraoxonase 1 - prognostic factor for one-year survival in patients with acute myocardial infarction
by: Ciumărnean Lorena, et al.
Published: (2018-07-01)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Gian Luca Erre, et al.
Published: (2022-11-01)

Arylesterase activity of paraoxonase 1 and intensity of oxidative processes in the blood of dialysis patients
by: L. Korol, et al.
Published: (2019-12-01)

Paraoxonase-1 Phenotype and Its Relationship with Mean Platelet Volume and Oxidative Stress in Coronary Artery Disease
by: Şahabettin SELEK, et al.
Published: (2015-08-01)

Comparison of Total Oxidative Stress, Total Antioxidant Capacity, and Paraoxonase, Arylesterase, and Lipid Peroxidase Levels in Aqueous Humor and Serum of Diabetic and Non-Diabetic Patients with Catarac
by: Cengiz Caner, et al.
Published: (2012-01-01)

Paraoxonase Activities in Metabolic Syndrome in Children and Adolescents
by: Arati Adhe-Rojekar, et al.
Published: (2018-01-01)

Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study
by: Christa Meisinger, et al.
Published: (2021-07-01)

Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients
by: Mehrdad Solati, et al.
Published: (2012-10-01)

Distribution of Paraoxonase 1 polymorphisms and activities in obese patients
by: Ciumărnean Lorena, et al.
Published: (2013-12-01)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
by: Muhammad Idrees, et al.
Published: (2018-07-01)

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
by: Irene Schilcher, et al.
Published: (2021-01-01)

Paraoxonase (PON1) 55 Polymorphism and Association with Systemic Lupus Erythematosus
by: Fariborz Bahrehmand, et al.
Published: (2013-09-01)

Paraoxonase-1 Regulation of Renal Inflammation and Fibrosis in Chronic Kidney Disease
by: Fatimah K. Khalaf, et al.
Published: (2022-04-01)

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender
by: Hamit Yasar Ellidag, et al.
Published: (2016-12-01)

The change of ghrelin levels in intestinal parasitic infections
by: Erensoy Ahmet, et al.
Published: (2010-01-01)

Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study
by: Celal Kilit, et al.
Published: (2017-04-01)

SERUM LEVELS OF OXIDATIVE STRESS PARAMETERS IN POSTMENOPAUSAL VERSUS FERTILE WOMEN OF KUTAHYA CITY, TURKEY
by: Behic Selman Erdogdu, et al.
Published: (2021-03-01)

Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
by: Anita Bosak, et al.
Published: (2020-01-01)

Adenomatöz kolon polipli hastalarda oksidatif stres mekanizmasının paraoksonaz ve arilesteraz üzerinden değerlendirilmesi
by: Ahmet Gürel, et al.
Published: (2013-01-01)

Paraoxonase gene polymorphisms: Understanding the biochemical and genetic basis of coronary artery disease
by: Fathima J. Nasreen, MD, et al.
Published: (2023-04-01)

The past and present of paraoxonase enzyme: Its role in the cardiovascular system and some diseases
by: Aydin Suleyman, et al.
Published: (2012-01-01)